The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-5B AML: Novel agents

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Nobuhiko Emi (Fujita Health University, Japan)

【Ｅ】

[OS1-5B-5] Gemtuzumab ozogamicin in children with relapsed or refractory AML: a single center experience

Fuminori Iwasaki, Wataru Nakamura, Sachio Fujita, Akiko Hayashi, Naoyuki Miyagawa, Tomoko Yokosuka, Satoshi Hamanoue, Masae Shiomi, Shoko Goto, Hiroaki Goto (Kanagawa Chirdren's Medical center, Hematology and Oncology,Yokohama, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password